Loading company…
Stamford genomics company founded in 2017 that develops diagnostic tests for biopharma, oncology and hereditary cancer.
Based in Connecticut, US, and founded in 2017, Mount Sinai Genomics, Inc., doing business as Sema4, develops genomics diagnostic testing solutions. Its work covers biopharma, oncology, women's health, COVID-19 and hereditary cancer. The company is at the Public stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in